世界の脳モニタリング機器市場...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
1.5.5 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW
3.1 INTRODUCTION
3.1.1 BRAIN MONITORING
3.1.2 IMPORTANCE OF BRAIN MONITORING
3.2 MARKET SEGMENTATION
3.2.1 BRAIN MONITORING DEVICES MARKET, BY PRODUCT
3.2.2 BRAIN MONITORING DEVICES MARKET, BY APPLICATION
3.3 MARKET DYNAMICS
3.3.1 DRIVERS
3.3.1.1 RISING INCIDENCE OF BRAIN DISORDERS, BRAIN INJURIES, SLEEP DISORDERS AND CEREBROVASCULAR DISEASES
3.3.1.2 INCREASING AWARENESS OF NEURODEGENERATIVE DISEASES
3.3.1.3 TECHNOLOGICAL ADVANCEMENTS IN BRAIN MONITORING DEVICES
3.3.2 RESTRAINT
3.3.2.1 SHORTAGE OF TRAINED PROFESSIONALS TO HANDLE BRAIN MONITORING DEVICES
3.3.3 OPPORTUNITIES
3.3.3.1 CLINICAL TRIALS FOR NEURO-COGNITIVE DISEASES IS ON THE RISE
3.3.3.2 BRAIN MONITORING DEVICES, A STANDARD IN CRITICAL CARE SETTINGS
3.4 MARKET SHARE ANALYSIS, BY KEY PLAYERS
3.4.1 ELECTROENCEPHALOGRAPH
3.4.1.1 NATUS MEDICAL, INC., A DOMINANT PLAYER IN THE EEG DEVICES MARKET (2012)
3.4.2 TRANSCRANIAL DOPPLER
3.4.2.1 NATUS MEDICAL, INC. AND DWL COMPUMEDICS, TOP PLAYERS IN THE TCD DEVICES MARKET (2012)
3.4.3 MAGNETOENCEPHALOGRAPH
3.4.3.1 ELEKTA AB AND YOKOGAWA ELECTRIC CORPORATION, KEY PLAYERS IN THE MEG DEVICES MARKET (2012)
3.4.4 INTRACRANIAL PRESSURE MONITOR
3.4.4.1 INTEGRA LIFE SCIENCES CORPORATION AND DEPUY SYNTHES, LEADING PLAYERS IN THE ICP DEVICES MARKET (2012)
3.4.5 CEREBRAL OXIMETER
3.4.5.1 COVIDIEN, PLC AND CAS MEDICAL SYSTEMS, PROMINENT PLAYERS IN THE CEREBRAL OXIMETER MARKET (2012)

4 GLOBAL BRAIN MONITORING DEVICES MARKET, BY PRODUCT
4.1 INTRODUCTION
4.1.1 EEG DEVICES DRIVING THE BRAIN MONITORING DEVICES MARKET GLOBALLY
4.2 ELECTROENCEPHALOGRAPH
4.2.1 TECHNICAL OVERVIEW
4.2.2 MARKET ANALYSIS
4.2.2.1 INTRODUCTION OF ADVANCED DIGITAL AND WIRELESS EEG EQUIPMENT HAS CREATED A SURGE IN THE MARKET
4.2.2.2 ASIAN EEG DEVICE MARKET IS SLATED TO GROW AT THE HIGHEST CAGR
4.3 TRANSCRANIAL DOPPLER
4.3.1 TECHNICAL OVERVIEW
4.3.2 MARKET ANALYSIS
4.3.2.1 ASIAN TCD DEVICES MARKET SHOWS ROBUST GROWTH
4.4 MAGNETOENCEPHALOGRAPH
4.4.1 TECHNICAL OVERVIEW
4.4.2 MARKET ANALYSIS
4.5 INTRACRANIAL PRESSURE MONITORS
4.5.1 TECHNICAL OVERVIEW
4.5.2 MARKET ANALYSIS
4.5.2.1 CONTINUOUS ICP MONITORING RECOMMENDATION FOR TBI PATIENTS IS SET TO DRIVE THE MARKET
4.5.2.2 ASIA WITH HIGHEST PERCENTAGE OF GLOBAL TBI PATIENTS PRESENTS HUGE POTENTIAL FOR GROWTH
4.6 CEREBRAL OXIMETERS
4.6.1 TECHNICAL OVERVIEW
4.6.2 MARKET ANALYSIS
4.6.2.1 CEREBRAL OXIMETER MARKET IS LIKELY TO GROW WITH INCREASE IN ITS CLINICAL APPLICATIONS
4.7 ACCESSORIES
4.7.1 TECHNICAL OVERVIEW
4.7.2 MARKET ANALYSIS
4.7.2.1 BATTERIES FORM THE LARGEST PRODUCT SEGMENT IN THE BRAIN MONITORING DEVICES ACCESSORIES MARKET
4.7.3 ELECTRODES
4.7.4 SENSORS
4.7.5 PASTE AND GELS
4.7.6 CAPS
4.7.7 CABLES
4.7.8 BATTERIES AND POWER SUPPLIES
4.7.9 OTHERS

5 GLOBAL BRAIN MONITORING DEVICES MARKET, BY APPLICATION
5.1 INTRODUCTION
5.1.1 EEG DEVICES DRIVE THE MARKET GLOBALLY OWING TO ITS WIDE APPLICATIONS
5.2 ELECTROENCEPHALOGRAPH
5.2.1 SLEEP DISORDERS REPRESENT THE LARGEST APPLICATION MARKET FOR EEG DEVICES
5.2.2 EPILEPSY
5.2.2.1 TECHNICAL OVERVIEW
5.2.2.2 MARKET ANALYSIS
5.2.2.2.1 RISING PATIENT POOL OF EPILEPSY AND AGING POPULATION IN NORTH AMERICA MAKES IT THE LARGEST EEG DEVICES MARKET FOR EPILEPSY
5.2.3 SLEEP DISORDERS
5.2.3.1 TECHNICAL OVERVIEW
5.2.3.2 MARKET ANALYSIS
5.2.3.2.1 RISING AWARENESS REGARDING SLEEP DISORDERS IS LIKELY TO PROPEL GROWTH OF THE EEG DEVICES MARKET
5.2.4 COMA & BRAIN DEATH
5.2.4.1 TECHNICAL OVERVIEW
5.2.4.2 MARKET ANALYSIS
5.2.4.2.1 LARGE NUMBER OF BRAIN INJURY ACCIDENTS IN NORTH AMERICA TO BOLSTER THE EEG DEVICES MARKET FOR COMA AND BRAIN DEATH
5.2.5 BRAIN TUMOR
5.2.5.1 TECHNICAL OVERVIEW
5.2.5.2 MARKET ANALYSIS
5.2.5.2.1 SHARP RISE IN THE BRAIN TUMOR RATES TO DRIVE THE EEG DEVICES MARKET IN NORTH AMERICA
5.2.6 OTHERS
5.3 TRANSCRANIAL DOPPLER
5.3.1 SUBARACHNOID HEMORRHAGE REPRESENTS THE LARGEST APPLICATION MARKET
5.3.2 INTRACRANIAL STENOSIS
5.3.2.1 TECHNICAL OVERVIEW
5.3.2.2 MARKET ANALYSIS
5.3.3 SUBARACHNOID HEMORRHAGE
5.3.3.1 TECHNICAL OVERVIEW
5.3.3.2 MARKET ANALYSIS
5.3.4 EMBOLI DETECTION
5.3.4.1 TECHNICAL OVERVIEW
5.3.4.2 MARKET ANALYSIS
5.3.5 SICKLE CELL DISEASE
5.3.5.1 TECHNICAL OVERVIEW
5.3.5.2 MARKET ANALYSIS
5.3.6 OTHERS
5.4 MAGNETOENCEPHALOGRAPH
5.4.1 BRAIN RESEARCH STUDIES, THE LARGEST APPLICATION AREA OF MEG DEVICES.
5.4.2 BRAIN RESEARCH STUDIES
5.4.2.1 TECHNICAL OVERVIEW
5.4.2.2 MARKET ANALYSIS
5.4.3 AUTISTIC DISORDERS
5.4.3.1 TECHNICAL OVERVIEW
5.4.3.2 MARKET ANALYSIS
5.4.4 OTHERS
5.5 INTRACRANIAL PRESSURE MONITORS
5.5.1 TRAUMATIC BRAIN INJURY, THE LARGEST APPLICATION AREA OF ICP DEVICES
5.5.2 TRAUMATIC BRAIN INJURY
5.5.2.1 TECHNICAL OVERVIEW
5.5.2.2 MARKET ANALYSIS
5.5.3 INTRACEREBRAL HEMORRHAGE
5.5.3.1 TECHNICAL OVERVIEW
5.5.3.2 MARKET ANALYSIS
5.5.4 MENINGITIS
5.5.4.1 TECHNICAL OVERVIEW
5.5.4.2 MARKET ANALYSIS
5.5.5 OTHERS
5.6 CEREBRAL OXIMETERS
5.6.1 CEREBRAL OXIMETER DEVICES MARKET IS DRIVEN BY CARDIAC/VASCULAR SURGERIES
5.6.2 CARDIAC/ VASCULAR SURGERY
5.6.2.1 TECHNICAL OVERVIEW
5.6.2.2 MARKET ANALYSIS
5.6.3 SHOULDER SURGERY
5.6.3.1 TECHNICAL OVERVIEW
5.6.3.2 MARKET ANALYSIS
5.6.4 SINGLE LUNG VENTILATION
5.6.4.1 TECHNICAL OVERVIEW
5.6.4.2 MARKET ANALYSIS
5.6.5 OTHERS

6 GLOBAL BRAIN MONITORING DEVICES MARKET, BY END-USER
6.1 INTRODUCTION
6.1.1 HOSPITALS ACCOUNTED FOR THE LARGEST SHARE OF THE BRAIN MONITORING DEVICES MARKET GLOBALLY
6.2 ELECTROENCEPHALOGRAPH
6.2.1 INCREASING NUMBER OF NEURO INTENSIVE CARE UNITS AND SLEEP CENTERS TO TRIGGER THE DEMAND FOR HOSPITAL-BASED EEG DEVICES
6.3 TRANSCRANIAL DOPPLER
6.3.1 HOSPITAL-BASED TCD DEVICES, CONSIDERED TO BE ‘STANDARD OF CARE’, FORMS THE LARGEST END-USER SEGMENT
6.4 MAGNETOENCEPHALOGRAPH
6.4.1 MEG DEVICES ARE LARGELY USED IN HOSPITALS AND RESEARCH INSTITUTES
6.5 INTRACRANIAL PRESSURE MONITOR
6.5.1 RISING NUMBER OF TRAUMA CENTERS EXPECTED TO BOOST THE DEMAND OF HOSPITAL-BASED ICP DEVICES
6.6 CEREBRAL OXIMETER
6.6.1 GROWTH IN THE FIELD OF CARDIAC CARE IS LIKELY TO PUSH THE DEMAND FOR HOSPITAL-BASED CEREBRAL OXIMETERS

7 GEOGRAPHIC ANALYSIS
7.1 INTRODUCTION
7.1.1 NORTH AMERICA AND EUROPE, DOMINATED THE BRAIN MONITORING DEVICES MARKET
7.1.2 ASIAN REGION IS POISED TO REGISTER THE HIGHEST CAGR IN THE COMING FIVE YEARS
7.2 NORTH AMERICA
7.2.1 INTRODUCTION OF TECHNOLOGICALLY ADVANCED AND DIGITALIZED DEVICES TO REVIVE THE MARKET
7.2.2 LARGE EPILEPSY PATIENT POOL AND INCREASE IN AGING POPULATION IS LIKELY TO FUEL THE DEMAND OF BRAIN MONITORING DEVICES
7.2.3 RISE IN THE NUMBER OF NEUROCRITICAL CARE UNITS IS SLATED TO DRIVE THE MARKET
7.2.4 REIMBURSEMENT SCENARIO, LIMITING THE GROWTH
7.3 EUROPE
7.3.1 LARGE NUMBER OF NEUROLOGICAL DISORDER PATIENTS IS LIKELY TO BOOST THE MARKET GROWTH
7.3.2 INCREASED EMPHASIS ON LONG TERM MONITORING OF EPILEPSY BY HOSPITALS IS EXPECTED TO IMPEL THE MARKET GROWTH
7.3.3 FINANCIALLY CHALLENGING CONDITIONS TO HINDER THE MARKET GROWTH
7.4 ASIA
7.4.1 ASIA SHOWCASES THE HIGHEST CAGR (2012 – 2017)
7.4.2 ASIAN MARKET TO BE PROPELLED BY INFLUX OF DEVICE MANUFACTURERS
7.4.3 INDIA AND CHINA OFFER HUGE MARKET POTENTIAL IN ASIAN REGION
7.4.4 RISING PREVALENCE OF EPILEPSY AND SLEEP DISORDERS IS LIKELY TO FUEL THE ASIAN MARKET GROWTH
7.4.5 HIGH COSTS OF DEVICES CURBING THE MARKET GROWTH
7.5 REST OF THE WORLD (ROW)
7.5.1 LATIN AMERICA, AUSTRALIA AND AFRICAN COUNTRIES ARE PROMISING GEOGRAPHIES

8 COMPETITIVE LANDSCAPE
8.1 INTRODUCTION
8.2 MERGERS & ACQUISITIONS
8.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, CONTRACTS AND JOINT VENTURES
8.4 NEW PRODUCT LAUNCH
8.5 EXPANSION
8.6 APPROVAL

9 COMPANY PROFILES(OVERVIEW, FINANCIAL, PRODUCTS & SERVICES, STRATEGY, AND DEVELOPMENTS)*
9.1 ADVANCED BRAIN MONITORING, INC.
9.2 ASTRO-MED, INC.
9.3 ATYS MEDICAL
9.4 CADWELL LABORATORIES, INC.
9.5 CAS MEDICAL SYSTEMS, INC.
9.6 COMPUMEDICS LIMITED
9.7 CONTEC MEDICAL SYSTEMS CO. LTD.
9.8 CORTECH SOLUTIONS, INC.
9.9 COVIDIEN, PLC
9.10 DEPUY SYNTHES COMPANIES
9.11 ELCAT GMBH
9.12 ELEKTA AB (PUBL)
9.13 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
9.14 MEG INTERNATIONAL SERVICES LIMITED
9.15 NATUS MEDICAL, INC.
9.16 NIHON KOHDEN CORPORATION
9.17 NONIN MEDICAL, INC.
9.18 RIMED, LTD.
9.19 YOKOGAWA ELECTRIC CORPORATION
*DETAILS ON OVERVIEW, FINANCIAL, PRODUCTS & SERVICES, STRATEGY AND DEVELOPMENTS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.